ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATYR ATYR PHARMA INC

已收盘 09-26 16:00:00 EDT

1.74

+0.02

+1.16%

盘后1.74

+0.000.00%

17:32 EDT

最高1.78	最低1.73	成交量11.12万
今开1.77	昨收1.72	日振幅2.91%
总市值1.32亿	流通市值1.28亿	总股本7,580万
成交额19.47万	换手率0.15%	流通股本7,381万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":1.74,"timestamp":1727380800000,"preClose":1.72,"halted":0,"volume":111235,"hourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.74,"latestTime":"17:32 EDT","volume":28,"amount":48.16,"timestamp":1727386352368},"delay":0,"floatShares":73808738,"shares":75796198,"eps":-0.905648,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"09-26 16:00:00 EDT","open":1.77,"high":1.78,"low":1.73,"amount":194680.1488265,"amplitude":0.02907,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.905648,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1727424000000},"adr":0,"listingDate":1430971200000,"adjPreClose":1.72,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.72,"latestTime":"09:08 EDT","volume":1350,"amount":2402.23995,"timestamp":1727356102487},"postHourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.74,"latestTime":"17:32 EDT","volume":28,"amount":48.16,"timestamp":1727386352368},"volumeRatio":0.438847,"impliedVol":0.632,"impliedVolPercentile":0.6203},"requestUrl":"/m/hq/s/ATYR/tweets","defaultTab":"tweets","newsList":[{"id":"2468000885","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.49%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468000885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468000885?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:52","pubTimestamp":1726764747,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时52分，Atyr Pharma, Inc.股票出现波动，股价急速上涨5.49%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.72%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Exicure, Inc.、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4783.36%、902.35%、206.93%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为106.99%、78.69%、52.97%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200052289719be53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200052289719be53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2465954512","title":"美国研究综述-可口可乐、KB Home、纽马克集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2465954512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465954512?lang=zh_cn&edition=full","pubTime":"2024-09-05 20:52","pubTimestamp":1725540777,"startTime":"0","endTime":"0","summary":"    路透9月5日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括可口可乐、KB Home 和 Newmark Group。* 可口可乐公司   ：CFRA将其评级从 \"买入 \"下调至 \"持有 * KB Home   ：加拿大皇家银行将其评级从 \"行业表现 \"下调至 \"表现不佳\"。* 纽马克集团  ：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","NMRK","DKS","BMRN","CMA","LU1951198990.SGD","MRCY","LH","JILL","CARR","CCEC","LOAR","LU2286300806.USD","OS","CPT","CACI","AVAV","BK4086","LU1868837136.USD","JWN","KB","AVAH","KBH","LZ","CHPT","X","PLAY","CNM","GNK","BASE","KREF","CASY","CE","CIEN","ARCB","LU1093756168.USD","LU1732800096.USD","BK4543","KO","LU1868836591.USD","ATYR","HUM","BBCP","ODFL","ABUS"],"gpt_icon":1},{"id":"2460717055","title":"Atyr Pharma, Inc.2024财年第二财季实现净利润-16.31百万美元，同比减少32.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717055","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717055?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:05","pubTimestamp":1723997134,"startTime":"0","endTime":"0","summary":"8月19日，Atyr Pharma, Inc.公布财报，公告显示公司2024财年第二财季净利润为-16.31百万美元，同比减少32.17%；其中营业收入为0.00美元，每股基本收益为-0.23美元。从资产负债表来看，Atyr Pharma, Inc.总负债24.52百万美元，其中短期债务1.17百万美元，资产负债比为0.05，流动比率为7.63。机构评级：截至2024年8月19日，当前有5家机构对Atyr Pharma, Inc.目标价做出预测，其中目标均价为24.60美元，其中最低目标价为16.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900054995a3877a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900054995a3877a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR"],"gpt_icon":0},{"id":"2459813290","title":"aTyr Pharma 公司报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459813290","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459813290?lang=zh_cn&edition=full","pubTime":"2024-08-14 04:23","pubTimestamp":1723580599,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc   报告，截至6月底的季度调整后每股亏损23美分，低于去年同期的每股收益-22美分。五位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股-27美分至-19美分。* aTyr Pharma Inc 公布的季度每股收益为亏损 23 美分。* 该公司当季亏损 1631 万美元。* aTyr Pharma Inc 的股价本季度上涨了 16.0%，今年迄今为止上涨了 28.4%。8月13日 - 预测变化   * 过去三个月，分析师的平均盈利预测下降了约 3.5%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 26.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2459132905","title":"aTyr Pharma 公司报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459132905","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459132905?lang=zh_cn&edition=full","pubTime":"2024-08-14 04:23","pubTimestamp":1723580599,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc   报告，截至6月底的季度调整后每股亏损23美分，低于去年同期的每股收益-22美分。五位分析师对该季度的平均预期是每股亏损 24 美分。华尔街预期为每股-27美分至-19美分。* aTyr Pharma Inc 公布的季度每股收益为亏损 23 美分。* 该公司当季亏损 1631 万美元。* aTyr Pharma Inc 的股价本季度上涨了 16.0%，今年迄今为止上涨了 28.4%。8月13日 - 预测变化   * 过去三个月，分析师的平均盈利预测下降了约 3.5%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 26.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"aTyr Pharma 公司报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2458518130","title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458518130","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458518130?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:46","pubTimestamp":1723218373,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc    将于8月12日公布截至2024年6月30日的季度业绩(估计)，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司预计将实现2.4万美元的营收。* LSEG 分析师对 aTyr Pharma Inc 的平均预期是每股亏损 24 美分。* 华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 26.00 美元，高于其上次收盘价 1.86 美元。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR"],"gpt_icon":0},{"id":"2457772274","title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457772274","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457772274?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:05","pubTimestamp":1722863113,"startTime":"0","endTime":"0","summary":"   * aTyr Pharma Inc    将于8月7日公布截至2024年6月30日的季度业绩(估计)，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司预计将实现2.4万美元的营收。* LSEG 分析师对 aTyr Pharma Inc 的平均预期是每股亏损 24 美分。* 华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 26.00 美元，高于上一次收盘价 1.83 美元。8月5日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"aTyr Pharma Inc   预计每股亏损24美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":-0.0549},{"period":"1month","weight":-0.1088},{"period":"3month","weight":0.1169},{"period":"6month","weight":-0.1179},{"period":"1year","weight":0.0818},{"period":"ytd","weight":0.2199}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"aTyr Pharma, Inc.于2005年9月8日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用进化智能将tRNA合成酶生物学转化为纤维化和炎症的新疗法。tRNA合成酶是古老的、必需的蛋白质，它们已经进化出新的结构域，在人类的胞外调节不同的途径。该公司的发现平台专注于通过发现由所有20种tRNA合成酶衍生的结构域专有库驱动的信号通路来解锁隐藏的治疗干预点。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.5,"avgChangeRate":-0.034182},{"month":7,"riseRate":0.5,"avgChangeRate":0.005168},{"month":8,"riseRate":0.1,"avgChangeRate":-0.079736},{"month":9,"riseRate":0.5,"avgChangeRate":0.100117},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.07207},{"month":11,"riseRate":0.555556,"avgChangeRate":0.026072},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.077972}],"exchange":"NASDAQ","name":"ATYR PHARMA INC","nameEN":"ATYR PHARMA INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATYR PHARMA INC,ATYR,ATYR PHARMA INC股票,ATYR PHARMA INC股票老虎,ATYR PHARMA INC股票老虎国际,ATYR PHARMA INC行情,ATYR PHARMA INC股票行情,ATYR PHARMA INC股价,ATYR PHARMA INC股市,ATYR PHARMA INC股票价格,ATYR PHARMA INC股票交易,ATYR PHARMA INC股票购买,ATYR PHARMA INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATYR PHARMA INC(ATYR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATYR PHARMA INC(ATYR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}